Loading...
M-COPA suppresses endolysosomal Kit-Akt oncogenic signalling through inhibiting the secretory pathway in neoplastic mast cells
Gain-of-function mutations in Kit receptor tyrosine kinase result in the development of a variety of cancers, such as mast cell tumours, gastrointestinal stromal tumours (GISTs), acute myeloid leukemia, and melanomas. The drug imatinib, a selective inhibitor of Kit, is used for treatment of mutant K...
Na minha lista:
| Udgivet i: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Public Library of Science
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5389679/ https://ncbi.nlm.nih.gov/pubmed/28403213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0175514 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|